---
document_datetime: 2023-09-21 20:39:18
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/enspryng-epar-all-authorised-presentations_en.pdf
document_name: enspryng-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9060281
conversion_datetime: 2025-12-21 12:20:41.745476
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|------------------------|---------------------------|------------------------------|---------------------------|-------------------------------------------|
| EU/1/21/1559/001 | Enspryng          | 120 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (polymer) | 1 ml (120 mg/ml)          | 1 pre-filled syringe                      |
| EU/1/21/1559/002 | Enspryng          | 120 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (polymer) | 1 ml (120 mg/ml)          | 3 (3 x 1) pre-filled syringes (multipack) |